Literature DB >> 31451185

Brain Injury in Infants with Critical Congenital Heart Disease: Insights from Two Clinical Cohorts with Different Practice Approaches.

Nathalie H P Claessens1, Vann Chau2, Linda S de Vries3, Nicolaas J G Jansen4, Stephanie H Au-Young2, Raymond Stegeman5, Susan Blaser6, Manohar Shroff6, Felix Haas7, Davide Marini8, Johannes M P J Breur7, Mike Seed8, Manon J N L Benders3, Steven P Miller2.   

Abstract

OBJECTIVES: To determine prevalence and risk factors for brain injury in infants with critical congenital heart disease (CHD) from 2 sites with different practice approaches who were scanned clinically. STUDY
DESIGN: Prospective, longitudinal cohort study (2016-2017) performed at Hospital for Sick Children Toronto (HSC) and Wilhelmina Children's Hospital Utrecht (WKZ), including 124 infants with cardiac surgery ≤60 days (HSC = 77; WKZ = 47). Magnetic resonance imaging was performed per clinical protocol, preoperatively (n = 100) and postoperatively (n = 120). Images were reviewed for multifocal (watershed, white matter injury) and focal ischemic injury (stroke, single white matter lesion).
RESULTS: The prevalence of ischemic injury was 69% at HSC and 60% at WKZ (P = .20). Preoperative multifocal injury was associated with low cardiac output syndrome (OR, 4.6), which was equally present at HSC and WKZ (20% vs 28%; P = .38). Compared with WKZ, HSC had a higher prevalence of balloon-atrioseptostomy in transposition of the great arteries (83% vs 53%; P = .01) and more frequent preoperative focal injury (27% vs 6%; P = .06). Postoperatively, 30% of new multifocal injury could be attributed to postoperative low cardiac output syndrome, which was equally present at HSC and WKZ (38% vs 28%; P = .33). Postoperative focal injury was associated with intraoperative selective cerebral perfusion in CHD with arch obstruction at both sites (OR, 2.7). Compared with HSC, WKZ had more arch obstructions (62% vs 35%; P < .01) and a higher prevalence of new focal injury (36% vs 16%; P = .01).
CONCLUSIONS: Brain injury is common in clinical cohorts of infants with critical CHD and related to practice approaches. This study confirms that the high prevalence of brain injury in critical CHD is a clinical concern and does not simply reflect the inclusion criteria of published research studies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31451185     DOI: 10.1016/j.jpeds.2019.07.017

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  A Uniform Description of Perioperative Brain MRI Findings in Infants with Severe Congenital Heart Disease: Results of a European Collaboration.

Authors:  R Stegeman; M Feldmann; N H P Claessens; N J G Jansen; J M P J Breur; L S de Vries; T Logeswaran; B Reich; W Knirsch; R Kottke; C Hagmann; B Latal; J Simpson; K Pushparajah; A F Bonthrone; C J Kelly; S Arulkumaran; M A Rutherford; S J Counsell; M J N L Benders
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-21       Impact factor: 3.825

2.  Early motor outcomes in infants with critical congenital heart disease are related to neonatal brain development and brain injury.

Authors:  Raymond Stegeman; Maaike C A Sprong; Johannes M P J Breur; Floris Groenendaal; Linda S de Vries; Felix Haas; Janjaap van der Net; Nicolaas J G Jansen; Manon J N L Benders; Nathalie H P Claessens
Journal:  Dev Med Child Neurol       Date:  2021-08-20       Impact factor: 4.864

Review 3.  A narrative review of modern approach and outcomes evaluation in congenital heart defects.

Authors:  Antonio F Corno; Damien J LaPar; Wen Li; Jorge D Salazar
Journal:  Transl Pediatr       Date:  2021-08

Review 4.  Antenatal and Perioperative Mechanisms of Global Neurological Injury in Congenital Heart Disease.

Authors:  Melinda Barkhuizen; Raul Abella; J S Hans Vles; Luc J I Zimmermann; Diego Gazzolo; Antonio W D Gavilanes
Journal:  Pediatr Cardiol       Date:  2020-12-29       Impact factor: 1.655

Review 5.  Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?

Authors:  Sara Ottolenghi; Giuseppina Milano; Michele Dei Cas; Tina O Findley; Rita Paroni; Antonio F Corno
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

6.  CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL): study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial.

Authors:  Raymond Stegeman; Maaike Nijman; Nicolaas J G Jansen; Manon J N L Benders; Johannes M P J Breur; Floris Groenendaal; Felix Haas; Jan B Derks; Joppe Nijman; Ingrid M van Beynum; Yannick J H J Taverne; Ad J J C Bogers; Willem A Helbing; Willem P de Boode; Arend F Bos; Rolf M F Berger; Ryan E Accord; Kit C B Roes; G Ardine de Wit
Journal:  Trials       Date:  2022-02-23       Impact factor: 2.279

7.  Fetal origin of brain dysmaturation in congenital heart disease - Challenges and opportunities for interventions.

Authors:  J J Volpe
Journal:  J Neonatal Perinatal Med       Date:  2022

8.  Analyzing Continuous Physiologic Data to Find Hemodynamic Signatures Associated With New Brain Injury After Congenital Heart Surgery.

Authors:  Jessica Nicoll; Jonathan Somer; Danny Eytan; Vann Chau; Davide Marini; Jessie Mei Lim; Robert Greer; Safwat Aly; Mike Seed; Steven P Miller; Peter C Laussen; Mjaye L Mazwi; Steven M Schwartz
Journal:  Crit Care Explor       Date:  2022-09-02

9.  Paediatric brain MRI findings following congenital heart surgery: a systematic review.

Authors:  Fatmah Jamal Alablani; Hoi Shan Asia Chan; Lucy Beishon; Nikil Patel; Alanoud Almudayni; Frances Bu'Lock; Emma Ml Chung
Journal:  Arch Dis Child       Date:  2022-03-22       Impact factor: 4.920

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.